Consent of Independent Auditors
We consent to the reference to our firm under the caption “Statement by Experts” and to the use of our report dated September 27, 2012, except as to note 16, which is as of August 11, 2014, with respect to the financial statements of Trillium Therapeutics Inc. in the Registration Statement on Form 20-F (Amendment No. 2) for the registration of common shares of Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.).
/s/ Ernst & Young LLP | |
Toronto, Canada | Chartered Professional Accountants |
November 26, 2014 | Licensed Public Accountants |